BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25622345)

  • 41. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
    Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
    J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Topical therapy of superficial basalioma and senile keratoma with 5-fluorouracil].
    Trnka J
    Cesk Dermatol; 1971 Oct; 46(5):187-91. PubMed ID: 5121700
    [No Abstract]   [Full Text] [Related]  

  • 43. [5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin].
    Ott F; Storck H
    Schweiz Med Wochenschr; 1971 Aug; 101(34):1243-4. PubMed ID: 5141782
    [No Abstract]   [Full Text] [Related]  

  • 44. Tumors of the skin. XI. Effect of occlusive dressing on the local administration of 5-fluorouracil to superficial basal cell carcinoma.
    Stoll HL; Klein E
    J Invest Dermatol; 1969 Mar; 52(3):304-6. PubMed ID: 5774360
    [No Abstract]   [Full Text] [Related]  

  • 45. [Remote results of treatment of basal cell epitheliomas of the skin with 5-fluorouracil].
    Chodynicka B
    Przegl Dermatol; 1981; 68(1):85-7. PubMed ID: 7244265
    [No Abstract]   [Full Text] [Related]  

  • 46. 5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
    Achten G; Van Oost A; Ledoux-Corbusier M
    Dermatologica; 1970; 140():Suppl 1:59-64. PubMed ID: 5471364
    [No Abstract]   [Full Text] [Related]  

  • 47. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
    Zala L
    Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
    [No Abstract]   [Full Text] [Related]  

  • 48. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
    Ebner H
    Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906
    [No Abstract]   [Full Text] [Related]  

  • 49. Electron microscopy studies on the effect of 5-fluorouracil on basaliomas.
    Ebner H
    Z Haut Geschlechtskr; 1971 Aug; 46(16):465-72. PubMed ID: 5572204
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
    Binazzi M
    Dermatologica; 1970; 140():Suppl 1:90-6. PubMed ID: 5471369
    [No Abstract]   [Full Text] [Related]  

  • 51. Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
    Klein E
    Proc Natl Cancer Conf; 1972; 7():567-78. PubMed ID: 4764924
    [No Abstract]   [Full Text] [Related]  

  • 52. [Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
    Uthida-Tanaka AM; Nakamura S; de Britto-Costa R; de Tavares Mello E
    Hospital (Rio J); 1969 Dec; 76(6):2207-20. PubMed ID: 5309543
    [No Abstract]   [Full Text] [Related]  

  • 53. Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib.
    Poulalhon N; Dalle S; Balme B; Thomas L
    Dermatology; 2015; 230(2):101-4. PubMed ID: 25633488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas].
    Goldberg H; Tsalik M; Bernstein Z; Haim N
    Harefuah; 1994 Oct; 127(7-8):217-21, 286. PubMed ID: 7813942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antineoplastic activity of 5-fluorouracil upon transdermal adminstration using "Coletex" napkins].
    Vartanian LP; Oltarzhevskaia ND; Vershinina SF; Gornaeva GF; Pustovalov IuI; Korovina MA
    Vopr Onkol; 2001; 47(4):472-4. PubMed ID: 11710293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum].
    Boussen H; Zwik J; Mili-Boussen I; Rammeh N; Bouaouina N; Gritli S; el May A; Kammoun MR; Ouertani A; Ladgham A
    Therapie; 2001; 56(6):751-4. PubMed ID: 11878102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review.
    Metterle L; Nelson C; Patel N
    J Am Acad Dermatol; 2016 Mar; 74(3):552-7. PubMed ID: 26577512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.
    Nguyen BT; Gan SD; Konnikov N; Liang CA
    J Am Acad Dermatol; 2015 Mar; 72(3):558-60. PubMed ID: 25687314
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
    Beach DF; Somer R
    J Clin Oncol; 2011 May; 29(14):e397-401. PubMed ID: 21357787
    [No Abstract]   [Full Text] [Related]  

  • 60. Intralesional fluorouracil injection in infantile digital fibromatosis.
    Oh CK; Son HS; Kwon YW; Jang HS; Kwon KS
    Arch Dermatol; 2005 May; 141(5):549-50. PubMed ID: 15897374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.